Corporate Social Responsibility Supply Chain to Value - amazonia.fiocruz.br

Corporate Social Responsibility Supply Chain to Value Video

Being commercially successful and operating responsibly is how we will generate sustainable returns for our shareholders and deliver on our purpose, to improve the quality of human life by helping people do more, feel better and Valud longer. Trust is essential to how we deliver on our purpose. We have 13 commitments across three focus areas that support our Trust priority.

Animal Welfare Position

We had positive pivotal data readouts and made regulatory submissions for three of our oncology assets — Zejulabelantamab mafodotin and dostarlimab. Our highly successful vaccine against shingles, Shingrixgained approval in China, and we launched Dovatoour new two-drug HIV regimen for treatment-naive patients. Read more in the Innovation section of our Annual Report.

We filed FDA and EU regulatory submissions for paediatric dolutegravir, our HIV medicine, in preparation for regulatory submissions in low and middle income countries. Read more here. When setting the price of our medicines in here markets, we apply a value-based approach to balance reward for innovation with access and affordability. In developing countries we use innovative pricing structures to extend product reach.

In least developed and low-income countries we do not file patents for our medicines and do not enforce historic patents. Use access strategies to reach million underserved people in developing countries with our products by We have reached over million people since through access strategies, including tiered pricing and product donations. Partner to improve disease prevention, awareness and access to healthcare services for Corporatf million people by Our access partnerships have reached nearly 8 million people since This includes, inreachingpeople to address HIV stigma and Corporate Social Responsibility Supply Chain to Value HIV eradication through our partnership with Positive Action for Children and reaching 2 million people through our Sociak worker training programme. Be a leading company in how we support employee health, wellbeing and personal development.

We provide a comprehensive preventive healthcare package for our employees in every country where we operate. In https://amazonia.fiocruz.br/scdp/blog/woman-in-black-character-quotes/introduction-the-project-research-is-all-about.php, more than 10, employees took part in our energy and resilience programmes. We have a strong focus on improving the effectiveness of our people managers. Read more about health and wellbeing clickand development here.

Realising this ambition will require private sector, governments and civil society to play their part and work together in new and innovative ways. It meets four times a year to provide high-level guidance and reviews performance against our commitments. Management of key non-financial risks is governed by our Audit and Risk Committee. The Audit and Assurance team supports this committee by providing an independent view to the Board and senior management of how risk is being managed across the business consistent with an agreed Assurance Plan. We welcome your feedback on our responsible business performance and reporting.

Conflict Minerals

You can also request to receive regular updates on our progress. Millions of people live with unmet healthcare needs. We want to help change this, using our scientific expertise, our partnerships and our global reach. We are changing the way we work to further embed our values more info everything we do, including the way we research, develop, sell and market our products. Learn how we create an inspiring and supportive work environment that encourages employees to develop capabilities and achieve their best.

To ensure we deliver high quality products to patients and consumers, we must protect the natural resources we need to make them today. You are currently visiting our global website.

Animal Welfare - Swine Assurance Position

Responsibility Responsible business is how we do business Being commercially successful and operating responsibly is how we will generate sustainable returns for our shareholders and deliver on our purpose, to improve the quality of human life by helping people do more, feel better and live longer. Key information Our approach to responsible business PDF - By using our science link technology to address health needs.

New medical innovations. Develop differentiated high-quality and needed medicines, vaccines and consumer healthcare products to improve health. Progress in We had positive pivotal data readouts and made regulatory submissions for three of our oncology assets — Zejulabelantamab mafodotin and dostarlimab. Global health.]